TREAT TO TARGET

You have access
What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis?
Laura C. Coates, Ennio Lubrano, Fabio Massimo Perrotta, Paul Emery, Philip G. Conaghan and Philip S. Helliwell

The Journal of Rheumatology January 1 2019, 46 (1) 38-42; DOI: https://doi.org/10.3899/jrheum.180267
You have access
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort
Nasir T. Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, Leah McWilliams, Anita T.Y. Lee, Llewellyn D. Spargo, Robert G. Metcalf, Cindy Hall, Susanna M. Proudman and Michael D. Wiese

The Journal of Rheumatology September 1 2016, 43 (9) 1643-1649; DOI: https://doi.org/10.3899/jrheum.151392
You have access
Early Local Swelling and Tenderness Are Associated with Large-joint Damage After 8 Years of Treatment to Target in Patients with Recent-onset Rheumatoid Arthritis
Marianne van den Broek, Linda Dirven, Herman M. Kroon, Margreet Kloppenburg, H. Karel Ronday, André J. Peeters, Pit J.S.M. Kerstens, Tom W.J. Huizinga, Willem F. Lems and Cornelia F. Allaart

The Journal of Rheumatology May 1 2013, 40 (5) 624-629; DOI: https://doi.org/10.3899/jrheum.121248

Main menu